首页> 外文期刊>日本腎臓学会誌 >Dilution index as a candidate parameter reflecting dialysis dose in combined peritoneal dialysis and hemodialysis therapy
【24h】

Dilution index as a candidate parameter reflecting dialysis dose in combined peritoneal dialysis and hemodialysis therapy

机译:稀释指数作为反映透析剂量的候选参数,腹膜透析和血液透析治疗中的透析剂量

获取原文
获取原文并翻译 | 示例
       

摘要

Combined peritoneal dialysis and hemodialysis therapy (combined therapy) is recognized as an effective alternate in peritoneal dialysis patients with insufficient water and solute removal, but there is no appropriate index for dialysis dose, as two distinct dialysis procedures are utilized in the same patient. Among several candidate parameters, the dilution index proposed and defined by Yamada, et al as the solute generation rate divided by the distribution volume and time-averaged concentration of the solute might be applicable, because it is unrelated to the method of solute removal. Among 11 patients undergoing combined therapy at Toride Kyodo General Hospital, six patients who had transferred from peritoneal dialysis alone to combined therapy were recruited. All patients received peritoneal dialysis therapy for five consecutive days followed by one day off dialysis before a hemodialysis session on the seventh day every week. Total weekly creatinine and urea removal by residual renal function, peritoneal dialysis, and hemodialysis were measured, and their solute removal on the last(5th) day under peritoneal dialysis was ascertained and correlated with the averaged daily removal of solutes. Hence the value of solute removal obtained on the last day under peritoneal dialysis was multiplied seven times and defined as the weekly solute generation. The distribution volumes of creatinine and urea were defined as 58% of body weight. The time-averaged concentration was obtained from the mean level of a solute before and after a hemodialysis session. During the period followed solely by peritoneal dialysis, the dilution indices for creatinine and urea were 1.22 +/- 0.14 and 1.85 +/- 0.14, respectively. The dilution index after transferring to combined therapy, calculated by the above-mentioned method was increased to 1.72 +/- 0.29 and 2.28 +/- 0.31, respectively. Hence the dilution index may be useful for reflecting dialysis doses even in combined therapy.
机译:组合腹膜透析和血液透析治疗(联合治疗)被认为是水分不足的腹膜透析患者的有效交替,但透析剂量没有适当的指标,因为在同一患者中使用了两个不同的透析程序。在几个候选参数中,由Yamada等溶液提出和定义的稀释指数作为溶质产生速率除以分布体积和溶质的时间平均浓度,可能与溶质去除方法无关。 11名患者在Tiride Kyodo综合医院接受联合治疗的患者中,招募了六名从腹膜透析转移到联合治疗的患者。所有患者均接受腹膜透析治疗连续五天,然后在每周第七天的血液透析会议之前透析透析。测量残留肾功能,腹膜透析和血液透析的总肌酸酐和尿素去除,并确定腹膜透析下的最后(第5天)的溶质去除并与平均每日去除溶质的溶质相关。因此,在腹膜透析下的最后一天获得的溶质去除的值相乘,并将其定义为每周溶质。肌酐和尿素的分布体积定义为体重的58%。时间平均浓度从血液透析会议之前和之后的溶质的平均水平获得。在该期间遵循腹膜透析,肌酐和尿素的稀释指数分别为1.22 +/- 0.14和1.85 +/- 0.14。转移到组合疗法后的稀释指数分别由上述方法计算为1.72 +/- 0.29和2.28 +/- 0.31。因此,即使在组合治疗中,稀释指数也可用于反映透析剂量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号